Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.
about
Current advances in biomarkers for targeted therapy in triple-negative breast cancerThe role of the insulin-like growth factor-1 system in breast cancerSignificance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival.High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
P2860
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Differential expression of the ...... early breast cancer subtypes.
@ast
Differential expression of the ...... early breast cancer subtypes.
@en
type
label
Differential expression of the ...... early breast cancer subtypes.
@ast
Differential expression of the ...... early breast cancer subtypes.
@en
prefLabel
Differential expression of the ...... early breast cancer subtypes.
@ast
Differential expression of the ...... early breast cancer subtypes.
@en
P2093
P2860
P1433
P1476
Differential expression of the ...... early breast cancer subtypes.
@en
P2093
Anastasios Stofas
Angelos Koutras
Chrisanthi Vamvouka
Dimitra Aivazi
Dimitrios Bafaloukos
Eleni Galani
Eleni Timotheadou
George Kouvatseas
George Pentheroudakis
Giannis Mountzios
P2860
P304
P356
10.1371/JOURNAL.PONE.0091407
P407
P577
2014-03-17T00:00:00Z